This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Conopco, Inc., Other. Active years: 2010-2015.
Location History:
- Long Hanborough, GB (2010 - 2015)
- Oxford, GB (2015)
Company Filing History:
1 out of 1,591 
2 out of 834,411 Years Active: 2010-2015
Title: The Innovative Contributions of Andrew James Elphick
Introduction
Andrew James Elphick is a notable inventor based in Long Hanborough, GB. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 3 patents. His work focuses on the development of processes that enhance the solubility and delivery of water-insoluble drugs.
Latest Patents
Elphick's latest patents include innovative processes for producing pharmaceutical compositions. One of his patents details a method for creating a composition that includes a water-insoluble sartan. This process involves providing a mixture of the sartan, a water-soluble carrier, and a solvent, followed by spray-drying to achieve a solvent-free nano-dispersion. Another patent outlines a similar process for water-insoluble paracetamol or NSAIDs, emphasizing the importance of achieving a solvent-free nano-dispersion for improved drug delivery.
Career Highlights
Throughout his career, Elphick has worked with various companies, including Conopco, Inc. His expertise in pharmaceutical formulations has positioned him as a valuable contributor to advancements in drug delivery systems. His innovative approaches have the potential to improve patient outcomes by enhancing the efficacy of medications.
Collaborations
Elphick has collaborated with notable professionals in his field, including David John Duncalf and Steven Paul Rannard. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.
Conclusion
Andrew James Elphick's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations. His patents reflect a deep understanding of the challenges associated with water-insoluble drugs and offer promising solutions for the pharmaceutical industry.